Meloxicam can cause skin rashes, though the reaction is uncommon. In clinical challenge studies of people already known to be sensitive to similar painkillers, only about 1 to 9 percent developed any skin-related symptoms, and those were mostly mild. The rashes that do occur range from faint redness and hives to rare but serious conditions that require emergency care. What matters is recognizing which type of rash you’re dealing with, because the appropriate response varies enormously depending on the pattern.
How Common Are Skin Reactions to Meloxicam
Meloxicam belongs to the oxicam family of nonsteroidal anti-inflammatory drugs (NSAIDs), and it preferentially targets a specific enzyme involved in inflammation. That selectivity is part of why it tends to be better tolerated than older, less selective NSAIDs. In a study that challenged patients who had already had bad reactions to other NSAIDs with meloxicam, positive reactions occurred in only about 1 percent of cases, and both of those reactions were limited to the skin: one person developed hives with facial swelling, and the other had a widespread flat rash with facial puffiness.
A larger study of 116 patients with histories of NSAID-triggered hives or swelling found that roughly 9 percent reacted to meloxicam, but the reactions were described as mild: hives, swelling, or just redness and itching. The remaining 91 percent tolerated it without any trouble. These numbers come from people who were specifically at higher risk because of prior NSAID sensitivity. For the general population taking meloxicam for joint pain or inflammation, the rate of skin problems is lower still.
Mild Rashes and Hives
The most frequently reported skin reactions to meloxicam are urticaria (hives) and maculopapular rashes. Hives show up as raised, itchy welts that can appear anywhere on the body. They tend to come on within minutes to hours of taking the drug and usually resolve once meloxicam is stopped. A maculopapular rash looks different: flat red patches mixed with small bumps, spread over a wider area. Both types surfaced in challenge testing as the primary skin-related complaints.1Annals of Allergy, Asthma & Immunology. Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs
Facial swelling (angioedema) sometimes accompanies these rashes, particularly around the lips and eyelids. It is not the same thing as anaphylaxis, though the two can overlap. If you notice hives spreading rapidly alongside swelling of the face, tongue, or throat, that warrants immediate medical attention rather than a wait-and-see approach. Plain hives that stay on the skin surface and don’t progress are less urgent, but you should still stop the drug and let your doctor know.
Fixed Drug Eruption
A fixed drug eruption is one of the more distinctive rash patterns linked to meloxicam. It produces a round, well-defined dark patch, often dusky red or purplish, that reappears in exactly the same spot every time you take the offending drug. Common locations include the genitals, lips, hands, and trunk. The “fixed” part of the name refers to the fact that the lesion is loyal to its location: the same patch of skin flares up repeatedly.
A recent case report documented a variant called fixed drug eruption inversus associated with meloxicam, in which the patches appeared in skin folds rather than the more typical exposed areas.2PubMed. Fixed Drug Eruption Inversus Associated With Meloxicam Fixed drug eruptions are not dangerous in most cases, but they can be alarming because of how dark the residual marks look once the active inflammation settles. Those post-inflammatory pigment changes can linger for months. The main risk is misidentification: because the patch returns to the same spot, people sometimes mistake it for a recurring infection or an unrelated skin condition, which delays the simple fix of switching to a different painkiller.
Severe Skin Reactions
At the far end of the severity spectrum are Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). These are medical emergencies in which the skin blisters and begins to peel off in sheets, often involving the mucous membranes of the mouth, eyes, and genitals. They are exceedingly rare with any individual drug, and the absolute risk with meloxicam remains very low.
A review of the literature found that oxicam-class drugs as a group had the strongest association with SJS and TEN among NSAIDs, but even then, the rate was estimated at fewer than two cases per million users per week. For other NSAIDs, the figure was under one per million users per week.3American Journal of Health-System Pharmacy. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature The review noted that meloxicam’s specific risk is less clear than that of older oxicams like piroxicam, partly because meloxicam entered the market after the major epidemiologic studies on SJS/TEN had already been completed.
An analysis of spontaneous adverse-event reports found that meloxicam appeared on a list of drugs suspected of causing SJS/TEN, but it was the only drug on the “highly suspect” list from a major European study that did not show a disproportionate spike in reporting compared to other medications. In other words, the raw reports existed, but the signal was not as strong as for many other drugs on the same list.4PubMed. Spontaneous adverse event reports of Stevens-Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications
Another study examined severe cutaneous adverse reactions caused by different NSAID classes and found that TEN was most common among people treated with enolic acids, the chemical subclass that includes meloxicam and piroxicam. That same analysis noted that mucosal involvement occurred in every case of enolic acid-induced severe skin reactions, though the average area of skin affected was actually smaller than with severe reactions from other NSAID classes.5PubMed Central. Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs The takeaway is that while meloxicam’s chemical family carries a somewhat higher relative association with SJS/TEN compared to, say, ibuprofen, the absolute risk is still tiny.
Drug Reaction with Eosinophilia and Systemic Symptoms
DRESS is a delayed hypersensitivity reaction that typically appears two to eight weeks after starting a new medication. It involves a widespread rash, fever, swollen lymph nodes, and organ involvement, often the liver or kidneys. DRESS is less commonly associated with NSAIDs than with drugs like anticonvulsants or antibiotics, but it does occur.
The same study that examined severe NSAID skin reactions found that DRESS was significantly more frequent among people taking coxib-class drugs (the highly selective COX-2 inhibitors like celecoxib) than among those taking other NSAIDs. Meloxicam, which is preferentially but not exclusively COX-2 selective, falls into a gray zone. It is technically classified among enolic acids rather than coxibs, but its pharmacologic profile sits closer to the coxib end of the spectrum than most older NSAIDs do.5PubMed Central. Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs If you develop a rash accompanied by fever and general malaise weeks after starting meloxicam, DRESS is worth considering, and it requires prompt evaluation with blood work.
Photosensitivity and Sun Exposure
Meloxicam can make your skin more vulnerable to ultraviolet light, a phenomenon researchers have been characterizing in laboratory studies. When skin cells were exposed to meloxicam and UVA radiation together, cell growth dropped in proportion to the drug concentration, and the cells showed signs of oxidative damage: lower levels of protective molecules, disrupted energy production in mitochondria, and altered cell division.6PubMed Central. The Assessment of Meloxicam Phototoxicity in Human Normal Skin Cells: In Vitro Studies on Dermal Fibroblasts and Epidermal Melanocytes
A follow-up study dug deeper into the mechanism and found that meloxicam combined with UVA radiation affected two key skin cell types differently. In fibroblasts (the structural cells of the deeper skin layer), the drug suppressed protective antioxidant enzymes. In melanocytes (the pigment-producing cells), it actually increased those same enzymes’ activity, but the net result was still oxidative stress in both cell types.7Toxicology in Vitro. Phototoxic action of meloxicam contributes to dysregulation of redox homeostasis in normal human skin cells – Molecular and biochemical analysis of antioxidant enzymes in melanocytes and fibroblasts The researchers suggested that melanin pigment itself may explain why the two cell types respond so differently.
In practical terms, if you are taking meloxicam and planning to spend time in the sun, ordinary sun-protection habits become more important. A rash that appears only on sun-exposed areas while you’re on the drug, particularly if it looks like an exaggerated sunburn, should raise the question of phototoxicity. The reaction resolves once you stop either the drug or the UV exposure, but repeated episodes can cause lingering pigmentation changes.
Why Meloxicam Causes Skin Reactions
NSAIDs work by blocking cyclooxygenase enzymes, which are involved in producing inflammatory signaling molecules.8Journal of Cutaneous Medicine and Surgery. NSAIDs in Dermatologic Therapy: Review and Preview This enzyme-blocking action is why they reduce pain and swelling, but it also shifts the balance of other chemical pathways in the body. When the production of certain protective molecules drops, the immune system can overreact in the skin, releasing histamine and other mediators that cause redness, swelling, and itching.
Some skin reactions to meloxicam are driven by this biochemical shift rather than by a true allergy. In allergic (immunologic) reactions, your immune system treats the drug molecule itself as a threat and mounts a targeted response. In non-allergic hypersensitivity, the reaction occurs because of the pharmacological effects of the drug on enzyme pathways, meaning any NSAID that works the same way could trigger a similar problem. A review of NSAID-induced skin reactions identified several overlapping mechanisms: disrupted enzyme activity, changes in inflammatory mediator levels, immune dysregulation, genetic susceptibility, and oxidative stress.9International Journal on ObGyn and Health Sciences. Understanding NSAID-Induced Skin Reactions: Implications for Patient Care
The distinction matters because it determines whether you can safely take a different NSAID. If your reaction is pharmacological (driven by enzyme blockade), switching to another NSAID that blocks the same enzyme is unlikely to help. If it is a true allergy to meloxicam’s specific chemical structure, a chemically unrelated NSAID might be fine.
Cross-Reactivity With Other NSAIDs
One of the most practical questions for anyone who develops a rash from meloxicam is whether they can take a different pain reliever. A large study that performed oral challenge tests in patients with confirmed NSAID hypersensitivity found that about 6 percent of those challenged with meloxicam reacted. Cross-reactivity was highest in people whose original NSAID reactions involved both skin and respiratory symptoms, reaching roughly 12 percent in that subgroup.10PubMed Central. Cross‐Reactive NSAID Hypersensitivity: Clinical Findings From Aspirin Provocation and Alternative Drug Challenge Testing For comparison, cross-reactivity to celecoxib was lower at about 2 percent in the same study, and acetaminophen (which is not technically an NSAID) triggered reactions in about 10 percent.
An earlier study found even better numbers: meloxicam was well tolerated in about 96 percent of patients with known NSAID hypersensitivity, and the reactions that did occur were limited to hives.11PubMed. Meloxicam tolerance in hypersensitivity to nonsteroidal anti-inflammatory drugs This helps explain why meloxicam is often chosen as the alternative NSAID for people who can’t tolerate ibuprofen or naproxen: it reacts with a narrower set of patients.
The flip side, of course, is that if meloxicam itself caused your rash, your doctor will typically look to a different drug class entirely. Acetaminophen, which works through a different mechanism, is usually the first suggestion, though even it is not universally safe for NSAID-sensitive patients, as that 10 percent cross-reactivity rate shows. Formal challenge testing under medical supervision is the gold standard for confirming which alternatives you tolerate.
How Challenge Testing Works
If there is uncertainty about whether meloxicam (or a potential replacement) is safe for you, allergists use graded oral challenge tests. These involve giving you incrementally increasing doses of the drug in a clinic setting where reactions can be managed immediately. A study that tested a simplified two-step protocol, giving two equal half-doses of meloxicam rather than a long stepwise sequence, found that 94.5 percent of patients with NSAID hypersensitivity tolerated it, and those who received etoricoxib (another selective NSAID) tolerated it 100 percent of the time.12International Archives of Allergy and Immunology. Meloxicam and/or Etoricoxib Could Be Administered Safely in Two Equal Doses during an Open Oral Challenge in Patients with Nonsteroidal Anti-Inflammatory Drug Hypersensitivity
Challenge testing is useful because skin-prick and blood tests for NSAID allergy are unreliable. Unlike penicillin allergy, where standardized skin tests exist, there is no validated skin test for NSAID hypersensitivity. The oral challenge remains the only reliable way to confirm or rule out a reaction.
Who Is at Higher Risk
Several factors increase the chance of developing a skin reaction to meloxicam or other NSAIDs. Older age, female sex, a history of atopic conditions like asthma or eczema, and certain genetic variations all appear to raise the risk.9International Journal on ObGyn and Health Sciences. Understanding NSAID-Induced Skin Reactions: Implications for Patient Care People who have already reacted to one NSAID are at meaningfully higher risk of reacting to another, though as discussed above, meloxicam is better tolerated than most in that group.
A separate population worth noting is patients with chronic hives (urticaria) unrelated to any drug. NSAIDs are well-known triggers for flare-ups in people with underlying chronic urticaria, and meloxicam is no exception. In a study specifically focused on patients with NSAID-induced hives and swelling, about 9 percent reacted to meloxicam at a standard dose, while the rest tolerated it and could use it as a safe alternative painkiller going forward.13PubMed. Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema
When to Seek Medical Help
Not every rash from meloxicam demands the same urgency. A few hives that appear hours after taking the drug and fade with an antihistamine are worth reporting to your doctor but are not an emergency. By contrast, certain features signal something more serious:
- Blistering or peeling skin: especially if it involves the mouth, eyes, or genitals. This pattern raises concern for SJS/TEN and warrants an emergency room visit.
- Fever with a rash: a combination that starts weeks into treatment may indicate DRESS. Blood tests for liver and kidney function are needed promptly.
- Rapid swelling: particularly of the tongue, throat, or face, which suggests angioedema that could compromise breathing.
- Spreading redness: a rash that starts small but expands rapidly over hours, especially if it involves mucous membranes, is more concerning than a static patch of hives.
For milder reactions, stopping meloxicam and taking an antihistamine is a reasonable first step while you wait to speak with your prescriber. Do not restart the drug on your own to “test” whether it was really the cause; a supervised challenge test is the safe way to answer that question.
Meloxicam Skin Reactions in Dogs and Cats
Meloxicam is widely prescribed in veterinary medicine for arthritis and post-surgical pain, and skin reactions in animals mirror some of the same patterns seen in people, though they are extremely rare. A case report documented a dog that developed skin and eye reactions after receiving meloxicam for a knee injury. Skin biopsies showed bleeding in the skin layers, endothelial cell changes, and sloughing of the outer skin, along with vasculitis (inflammation of blood vessel walls) in the deeper dermis.14PubMed. Cutaneous and ocular adverse reactions in a dog following meloxicam administration
A broader review of drug hypersensitivity reactions in dogs and cats confirmed that meloxicam has been reported to cause neutrophilic vasculitis in at least one dog treated for a ligament injury.15Journal of Veterinary Internal Medicine. Drug Hypersensitivity Reactions Targeting the Skin in Dogs and Cats The rarity of published veterinary cases suggests the overall risk is very low, but pet owners who notice unusual skin lesions, hair loss, or eye redness in an animal taking meloxicam should contact their veterinarian. As with humans, the key is stopping the drug early enough that the reaction doesn’t progress.